Monoclonal Gammopathy-Associated Neuropathy

Area of Science:

• Neurology
• Hematology
• Oncology

Background:

• Peripheral neuropathy (PN) is a known complication of monoclonal gammopathies.
• Individuals with IgM monoclonal gammopathy or Waldenström macroglobulinemia have a higher incidence of PN.

Purpose of the Study:

• To review common PN syndromes associated with monoclonal gammopathies.
• To discuss the diagnosis and management of these complex conditions.
• To outline current therapeutic strategies for monoclonal gammopathy-associated PN.

Main Methods:

• Literature review of common PN syndromes in monoclonal gammopathy patients.
• Analysis of diagnostic challenges and management approaches.
• Synthesis of information on therapeutic interventions.

Main Results:

• Monoclonal gammopathies, especially IgM types, are strongly associated with PN.
• Several PN syndromes are linked to paraprotein deposition or immune mechanisms.
• Effective management requires collaboration between hematologists/oncologists and neurologists.

Conclusions:

• Understanding the diverse PN syndromes associated with monoclonal gammopathies is crucial.
• Timely diagnosis and multidisciplinary management improve patient outcomes.
• Current therapies offer options for treating these challenging neurological conditions.